We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fast and Easy Test Could Revolutionize Blood Transfusions

By LabMedica International staff writers
Posted on 27 Jan 2026

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. More...

Although blood units have a fixed expiration date, cells from different donors age at different rates, which can affect how well transfusions work, especially in vulnerable patients. Researchers have now developed a fast, chip-based test that can rapidly evaluate red blood cell quality after storage, offering a potential new tool to better manage blood supplies.

The test, developed through a collaboration between the University of Colorado Boulder (Boulder, CO, USA) and the University of Colorado Anschutz (Aurora, CO), fits on a single microchip and is designed to deliver results in about two minutes. The device, called a surface acoustic wave hemolysis assay, uses vibrations generated on a lithium niobate wafer to mechanically stress red blood cells. As the cells heat up and rupture, the system captures information that reflects membrane strength and overall cell health.

In laboratory tests using donor red blood cells, the researchers observed that some samples hemolyzed at lower temperatures than others. These samples also showed distinct metabolite patterns previously linked to aging red blood cells. The findings, published in Lab on a Chip, suggest that older or more fragile cells break down faster under acoustic stress, making the method a potential indicator of blood quality after storage.

If validated further, the chip-based test could help blood centers allocate higher-quality units to patients who need them most, such as children or individuals with conditions like sickle cell disease who require frequent transfusions. It may also reduce waste by improving decision-making around stored blood. In addition to transfusion medicine, the researchers believe similar lab-on-a-chip systems could be adapted to screen for blood-related diseases or monitor protein and metabolite changes linked to various health conditions.

“Our vision is to have a chip the size of a dime that you can plug into your cell phone,” said Associate Professor Xiaoyun Ding, senior author of the study. “It could use your phone’s camera and an app to read out the results in just two minutes.”

Related Links:
University of Colorado Boulder
University of Colorado Anschutz


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The SuperFlex prenatal screening system brings rapid, decentralized biochemistry‑based prenatal screening into small and mid‑sized laboratories (Photo courtesy of Revvity)

Compact Prenatal Screening System Expands Access to Preeclampsia Testing

Preeclampsia affects an estimated 2%–8% of pregnancies and is rising globally with increasing maternal age, diabetes, and hypertension. While international guidelines recommend screening, access often... Read more

Molecular Diagnostics

view channel
Image: Multiple levels in sequencing-based liquid biopsy analyses. (Molina, M.A., De Simoni, M., Moldovan, N. et al. Multifeature sequencing-based liquid biopsy for cancer diagnosis and monitoring. Genome Med 18, 116 (2026). https://doi.org/10.1186/s13073-026-01739-2)

Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis

Detecting and monitoring cancer often requires repeated tissue biopsies, which are invasive and not always feasible. Liquid biopsy offers a less invasive way to track disease over time, but many assays... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.